Comerica Bank
FOLD

Comerica Bank’s Amicus Therapeutics FOLD Stock Holding History

Comerica Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$405K Sell
28,452
-1,951
-6% -$19.2K ﹤0.01% 1947
2025
Q3 		$240K Buy
30,403
+31
+0.1% +$221 ﹤0.01% 2252
2025
Q2 		$174K Buy
30,372
+2,240
+8% +$14.5K ﹤0.01% 2377
2025
Q1 		$230K Sell
28,132
-46,688
-62% -$432K ﹤0.01% 2230
2024
Q4 		$705K Buy
74,820
+626
+0.8% +$6.51K ﹤0.01% 1731
2024
Q3 		$792K Sell
74,194
-2,700
-4% -$29.4K ﹤0.01% 1673
2024
Q2 		$763K Sell
76,894
-16,980
-18% -$174K ﹤0.01% 1639
2024
Q1 		$1.11M Sell
93,874
-9,544
-9% -$122K ﹤0.01% 1485
2023
Q4 		$1.47M Buy
103,418
+774
+0.8% +$8.79K 0.01% 1331
2023
Q3 		$1.25M Sell
102,644
-60,924
-37% -$786K 0.01% 1316
2023
Q2 		$883 Buy
+163,568
New +$1.94M 0.09% 23
2022
Q4 		$893K Buy
+71,901
New +$809K 0.01% 1502

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Comerica Bank's FOLD Position: Q4 2025 in Review

Comerica Bank reduced its Amicus Therapeutics (FOLD) stake by 6.4% in Q4 2025, selling an estimated $19.2K and leaving 28,452 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #1947.

Comerica Bank first reported a position in FOLD in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.47M in Q4 2023. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.

  • Comerica Bank held 28,452 shares of Amicus Therapeutics worth $405K as of Q4 2025.
  • Comerica Bank sold 1,951 Amicus Therapeutics shares in Q4 2025, an estimated $19.2K.
  • Amicus Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1947 holding.
  • Comerica Bank first reported a position in Amicus Therapeutics in Q4 2022 and has held it in 12 quarters since.
  • Comerica Bank's Amicus Therapeutics position peaked at $1.47M in Q4 2023.
  • 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.